CT45A1 Antibodies

AND CT45A1 ELISA kits, CT45A1 Proteins

Many biological assays use antibodies to detect CT45A1, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with CT45A1 in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop CT45A1 antibodies...

We validate the specificity of these antibodies to CT45A1 by testing them on tissues known to express CT45A1 positively and negatively. Browse below to find the CT45A1 antibody that suites your experiment. We have 1 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: Septin9 Next: C8orf58

CT45A1 Infographic by Boster Bio

All CT45A1 Products

Filter by Application:

Product

Figures

Specificity

Applications

Price

CT45A1 (NM_001017417) Human Over-expression Lysate

Human

$628
Cat # LS541466
100 µg

CT45A1 Overview

Facts about Cancer/testis antigen family 45 member A1.

CT45A1 3D structure. Source: alphafold

Cancer/testis antigen family 45 member A1 (CT45A1)

Gene Information

Human
Gene Name:	CT45A1
Uniprot:	Q5HYN5
Entrez:	541466

Family

Belongs to:

CT45 family

Alternative Names

Cancer/testis antigen 45-1; Cancer/testis antigen 45A1; cancer/testis antigen CT45-1; cancer/testis antigen family 45 member A1; cancer/testis antigen family 45, member A1; CT45; CT45.1; CT45-1XX-FW88277B6.1

Molecular Weight

Mass (kDA):
21.273 kDA

Genomic Context


Human

Location:	Xq26.3
Sequence:	X; NC_000023.11 (135708398..135723318)

Tissue Specificity

Testis specific. Expressed in cancer cell lines.

Diseases

Leukemia, Myelocytic, Acute
Leukemogenesis
Acute Biphenotypic Leukemia
Acute Leukemia
Leukemia

For details, visit:
bosterbio.com/bosterbio-gene-info-cards/CT45A1

References

PMID: 15905330 by Chen Y.-T., et al. Identification of cancer/testis-antigen genes by massively parallel signature sequencing.